MY197339A - Uses of biological compounds from toxoplasma sp and related compounds - Google Patents

Uses of biological compounds from toxoplasma sp and related compounds

Info

Publication number
MY197339A
MY197339A MYPI2010003223A MYPI2010003223A MY197339A MY 197339 A MY197339 A MY 197339A MY PI2010003223 A MYPI2010003223 A MY PI2010003223A MY PI2010003223 A MYPI2010003223 A MY PI2010003223A MY 197339 A MY197339 A MY 197339A
Authority
MY
Malaysia
Prior art keywords
toxoplasma
compounds
present
biological
infection
Prior art date
Application number
MYPI2010003223A
Inventor
Rahmah Noordin Prof
Saadatnia Geita
Zeehaida Mohamed Dr
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Priority to MYPI2010003223A priority Critical patent/MY197339A/en
Priority to PCT/MY2010/000141 priority patent/WO2012005563A1/en
Publication of MY197339A publication Critical patent/MY197339A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/45—Toxoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a plurality of biological compounds, and uses thereof. There is provided a method for detecting, in a biological sample, substances produced by or present in Toxoplasma sp., or substances produced by or present in a human or animal body in response to Toxoplasma sp. infection, using a biomarker wherein said biomarker is characterized by, derived from or made using said biological compounds. The present invention also provides for the use of these biological compounds in a medicament for treating Toxoplasma sp. infection or a disease resulting therefrom, as well as their use in the manufacture of a product for diagnosis, treatment, management or prophylaxis of Toxoplasma sp. infection or a disease resulting therefrom.
MYPI2010003223A 2010-07-07 2010-07-07 Uses of biological compounds from toxoplasma sp and related compounds MY197339A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI2010003223A MY197339A (en) 2010-07-07 2010-07-07 Uses of biological compounds from toxoplasma sp and related compounds
PCT/MY2010/000141 WO2012005563A1 (en) 2010-07-07 2010-08-11 Uses of biological compounds from toxoplasma sp and related compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2010003223A MY197339A (en) 2010-07-07 2010-07-07 Uses of biological compounds from toxoplasma sp and related compounds

Publications (1)

Publication Number Publication Date
MY197339A true MY197339A (en) 2023-06-13

Family

ID=45441386

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010003223A MY197339A (en) 2010-07-07 2010-07-07 Uses of biological compounds from toxoplasma sp and related compounds

Country Status (2)

Country Link
MY (1) MY197339A (en)
WO (1) WO2012005563A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618680B1 (en) * 1987-07-31 1990-05-11 Pasteur Institut TOXOPLASMA GONDII SPECIFIC EXCRETION-SECRETION ANTIGENS, THEIR EXPRESSION PRODUCTS, THE PROCESS FOR OBTAINING SAME AND THEIR DIAGNOSTIC AND PROPHYLACTIC APPLICATIONS

Also Published As

Publication number Publication date
WO2012005563A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
EA201290078A1 (en) HETEROCYCLIC COMPOUNDS TO INHIBIT PASK
WO2010091049A3 (en) Diagnosis and treatment of cancer
EA201490004A1 (en) BIFIDOBACTERIUM LACTIS BL-04 APPLICATION FOR TREATMENT OF RESPIRATORY DISEASES
EA200900177A1 (en) SUBSTITUTED ACYLANILIDES AND METHODS OF THEIR APPLICATION
EA201290836A1 (en) RELATED BIS-ARYL ARYLTRIAZOLONES AND THEIR APPLICATION
PH12013500889A1 (en) Improved algorithm for detection of diabetes
EP2180896A4 (en) Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs
BRPI1013705A2 (en) compounds, pharmaceutical composition, method of treating disease or condition associated with trap1 function and uses of compounds and pharmaceutical composition
BR112014029655A2 (en) tissue preparation device, and method for preparing tissue
PH12013500892B1 (en) Composition for use in the prevention and\or treatment of skin conditions and skin diseases
UA90048C2 (en) Conditioned blood composition and method for its production
MX2015000863A (en) Anti-siglec-15 antibodies.
EA201390826A1 (en) PYRIMIDINOUS CONNECTIONS FOR USE IN TREATING DISEASES OR STATES MEDIATED BY Lp-PLA
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism
MX2012012075A (en) MOLECULES AND METHODS TO USE THEM TO TREAT DISEASES ASSOCIATED WITH ERBB / ERBB LIGANDS.
BR112013026680A2 (en) compound, method of treating an inflammatory disease and pharmaceutical composition
IL220318A (en) Aqueous solutions containing 3-quinoclidinones for the treatment of diseases of overgrowth, autoimmunity and heart disease
EA201591773A1 (en) MACRO CYCLIC INHIBITORS RIP2-KINASE
BRPI0908719A2 (en) Methods of diagnosis, prevention and treatment of bone mass diseases
MY179250A (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
EP2606909A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT, PREVENTION AND DIAGNOSIS OF CANCER CONTAINING CANCER STEM CELLS OR THEREOF
IL211347A (en) Butyril-cholinastase compounds, their uses for the treatment of neurological diseases and diagnostic methods of neurological diseases
EP2538963A4 (en) METHOD FOR TREATING OR PREVENTING HAIR LOSS OR STIMULATING HAIR GROWTH
WO2012078648A3 (en) Novel method of cancer diagnosis and prognosis and prediction of response to therapy
EA201270176A1 (en) DERIVATIVES OF TAZAROTENES